Alere INRatio2 Recall Letter FDA FINAL Version w ID INFO 2026

Definition & Meaning

The Alere INRatio2 Recall Letter FDA FINAL Version w ID INFO is an urgent recall notice aimed at informing healthcare providers and users about the discontinuation and recall of INRatio®2 PT/INR Professional Test Strips (PN 99008G2) by Alere San Diego. The form serves as an official communication from the FDA and Alere, guiding recipients on the necessary steps to follow in response to the recall. It acts as both a notification and an acknowledgment form, requiring recipients to confirm receipt and provide details about discontinuation and return of the recalled product.

Purpose of the Recall Letter

• Notification: Alerts users about the safety issues with the INRatio2 strips.
• Acknowledgment: Recipients must confirm the receipt and understanding of the recall.
• Instruction: Provides specific steps to follow, including discontinuation of use and process for returning the product.

Components of the Recall Letter

• Product Details: Identifies the specific test strips subject to recall.
• Safety Information: Explains the reasons for the recall and potential risks involved.
• Response Form: Includes a reply section to confirm actions taken regarding the recall.

Receipt and Acknowledgment

1. Read Thoroughly: Carefully review all information provided in the recall letter.
2. Confirm Receipt: Complete the acknowledgment section of the form, affirming you have received and understood the recall notice.

Discontinuing Use

• Cease Usage Immediately: Stop using the INRatio2 test strips as instructed for safety purposes.
• Inform Relevant Parties: Notify all team members or patients who may be affected by the recall.

Return Process

1. Specify Return Quantity: Indicate the number of strips or kits to be returned.
2. Complete the Reply Section: Ensure all required fields in the reply form are filled accurately.
3. Submit the Form: Return the completed form via fax or email, as per the instructions provided.

Preparation

• Gather Information: Collect all relevant data, including the number of test strips in your possession and any usage logs.

Completing the Form

1. Identification Information: Fill in your contact details and any identification number provided by Alere.
2. Discontinuation Confirmation: Clearly indicate that you have ceased using the product.
3. Return Details: Provide accurate information on the quantity of unused product being returned.

Submission

• Method: Choose your preferred submission method (fax or email).
• Deadline: Ensure you comply with the 10-business-day submission deadline to avoid penalties.

Safety Warnings

• Health Risks: The letter outlines specific health risks associated with the continued use of the recalled strips.

Return Instructions

• Shipping Details: Clear instructions regarding where and how to send returned products.

Compliance

• Mandatory Actions: Detailed steps that must be taken to comply with the recall successfully.

Healthcare Providers

• Primary Target: Physicians, clinics, and hospitals using the INRatio2 PT/INR Test Strips for patient management.

Patients

• Individual Users: Patients who independently manage their health and use the INRatio2 system.

FDA Compliance

• Legal Requirements: The letter stresses adherence to FDA regulations regarding recalled medical products.

Record Keeping

• Documentation: Recipients must keep records of their receipt and response to the recall for legal compliance.

Use Case Scenarios

• Clinic Scenario: A healthcare provider receives the recall letter, confirms discontinuation of strips, and returns any unused supplies.
• Patient Scenario: An individual user receives the letter, discontinues product use, and seeks guidance from a healthcare provider for alternatives.

Consequences

• Legal Implications: There could be legal repercussions for not responding to the recall, including potential health liability.
• Regulatory Penalties: Failure to comply may result in penalties from regulatory bodies such as the FDA.